Taizhou Mabtech Pharmaceutical Co.,ltd

This study is testing a new version of a drug called omalizumab (CMAB007) for people with chronic hives that don't respond to standard allergy pills. It will compare this new version directly to the already-approved drug Xolair to see if they work the same. About 392 participants…

This is the first study in people to test a new drug called CMAB017 for advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 55 patients with various advanced cancers will rece…

This study aims to see if a new way of making the drug EnliTuo® works the same as the old way in the body. Researchers will give a single dose to healthy male volunteers and closely measure how the drug moves through and leaves the body, its safety, and if it triggers an immune r…